Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

PBD Biotech closes seed investment round

PBD Biotech Ltd is delighted to announce that it has successfully completed an over-subscribed seed investment round composed of angel investment from Cambridge Agritech Ltd and Anglia Capital Group.
  • August 24, 2017
  • Bovine TB

Previously, the Company had initiated its activities based on funding from the University of Nottingham Governance board and a grant received from the Greater Cambridge Greater Peterborough LEP’s Eastern Agri-Tech Growth Initiative to support its innovative technology for rapid, accurate and sensitive diagnosis of bacterial infection in animals.

Terms of the investment were not disclosed but Dr Berwyn Clarke (CEO) commented that “the investment will allow the company to further develop its manufacturing requirements and to progress its global commercialisation activities that are already attracting significant interest from many parts of the world”.

Speaking on behalf of Anglia Capital Group (ACG), Hannah Smith, Business Manager, said: “Few companies have generated so much interest from our members. PBD meets so many of the key criteria investors look for, such as ground-breaking technology, experienced management, clear route to market and an exit strategy.”

ACG member and investor in PBD Bio, Marcus Armes, added “We had a really strong line-up at the last investor event, but PBD Biotech really stood out. It’s a focused company with an unusual blend of scientific talent and business acumen. There is a crying need for a simple, speedy but reliable diagnostic for bovine TB and I believe Berwyn and the PBD team have produced the goods.”

Marcus added: “I was also attracted by the international potential of the product and it is pleasing to see that the technology has recently won an award in Canada.”

PBD Biotech has developed a novel and highly accurate method for rapidly detecting the presence of mycobacteria in blood, milk and other tissues that may have transformational benefits for both food quality assurance and the control of tuberculosis in animals.

Share:

Related posts

Loading...

Which is the best test for bovine TB?

October 14, 2021
The current ‘test and cull’ approach to control of bovine TB does not provide farmers and their vets with effective tools to help prevent and manage the disease

Which is the best test for bovine TB?

October 14, 2021
The current ‘test and cull’ approach to control of bovine TB does not provide farmers and their vets with effective...
Johne's Disease testing service

Heartbreak and hope – the story of a new diagnostic for bovine TB

June 30, 2021
Former dairy farmer Jonnie Yewdall joined vets, farmers and others to discuss a new hope of ending the bTB heartache at an Agri-TechE hosted webinar.
Johne's Disease testing service

Heartbreak and hope – the story of a new diagnostic for bovine TB

June 30, 2021
Former dairy farmer Jonnie Yewdall joined vets, farmers and others to discuss a new hope of ending the bTB heartache...
David Christensen

Actiphage to offer greater decision support in the fight against Bovine TB

May 14, 2021
“From an industry perspective bovine tuberculosis (bTB) is a huge problem – the disease continues to move across the UK, and we don’t appear to be getting on top of it. We need many more tools in the toolbox in...
David Christensen

Actiphage to offer greater decision support in the fight against Bovine TB

May 14, 2021
“From an industry perspective bovine tuberculosis (bTB) is a huge problem – the disease continues to move across the UK,...
Cow on Lammas Land Bovine TB eradication

BVA advocates One Health approach to Bovine TB eradication

August 4, 2020
Allowing farmers with Official Tuberculosis Free (OTF) status to use APHA approved but currently un-validated tests for Bovine TB (bTB) is one of the recommendations of the British Veterinary Association (BVA) in its recent policy statement. PBD Biotech, developers of...
Cow on Lammas Land Bovine TB eradication

BVA advocates One Health approach to Bovine TB eradication

August 4, 2020
Allowing farmers with Official Tuberculosis Free (OTF) status to use APHA approved but currently un-validated tests for Bovine TB (bTB)...
1 2 … 5 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More